Latest Euphoriants Stories
The ArcView Group hosts news conference to announce angel investments in this promising sector. SEATTLE, April 24, 2013 /PRNewswire/ -- On Monday, April 29, 2013, more than 40 high-net-worth investors from around the world will gather in Seattle to hear pitches from the top entrepreneurs in the hot, new legal cannabis industry. The private event is hosted by The ArcView Investor Network. A news conference to announce some of the first funded deals will be held immediately...
Cannabis Quitter is an online drug rehabilitation group that helps and supports people with a drug addiction. Los Angeles, CA (PRWEB) April 23, 2013 Cannabis Quitter is a new website for online drug rehabilitation groups. Cannabis Quitter serves as a caring service for recovering drug addictions or abuse with marijuana. People who are involved with drug abuse or drug addictions can go to the Cannabis Quitter website to learn more about dealing with problems and connecting with people who...
Lawrence LeBlond for redOrbit.com - Your Universe Online Cannibas (marijuana) has been a commonly used form of medicine throughout the Western world since the late 19th century. It was used as a primary source of pain relief until the invention of aspirin in 1897. While cannibas never really left the medicinal world, more modern medicines through the years took center stage as more potent forms of pain relief. However, medicinal marijuana began to come out of the woodwork again in the...
MIAMI, April 22, 2013 /PRNewswire-USNewswire/ -- Fuisz Pharma today announced its intent to divest its strategic issued patent for the detection of opioid abuse (US 7,214,385 "Pharmaceutical Formulation Containing Dye"). This patent covers the use of dyes and staining agents in pharmaceutical dosage forms as a method to prevent the improper use of opioid drugs by visually demonstrating their misuse and abuse. For example, where a patient abuses a drug like oxycodone through nasal...
FLEMINGTON, N.J., April 18, 2013 /PRNewswire/ -- Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids. This is in response to the Food and Drug Administration's recent announcement that they will not approve any generic to the original version of OxyContin® extended release oxycodone. The currently marketed version of OxyContin® possesses abuse-deterrent properties which the original...
Free is good; every dollar counts in this economy today and, Pure Health Group, a Denver based company which helps people get through opiate withdrawal side effects to lead sober lives, recognizes everyone could use a little more spare change in their pockets. That's why they are now offering complimentary standard shipping for their customers, anywhere in the United States, for any order. Denver, CO (PRWEB) April 17, 2013 Free is good; every dollar counts in this economy today and,...
US Medical Marijuana Sales could top $1.5B in 2013, Cannabis Revenues Could Quadruple by 2018 FOLSOM, CA, April 17, 2013 /PRNewswire/ - Anything Technologies Media, Inc. (Pink Sheets: EXMT) today announced that the company is shifting its focus to the exploding Medical Marijuana opportunity in 2013 and beyond. The company will still continue to do manufacturing for a wide variety of media and other products, but looks to devote most of its efforts to the Marijuana Industry....
Lawrence LeBlond for redOrbit.com - Your Universe Online Purdue Pharma’s OxyContin, a name-branded narcotic pain killer using the oxycodone formula, has long been a source of abuse for addicts. In a move to reduce that risk of abuse, Purdue in 2010 developed reformulated OxyContin tablets that would make it difficult for abusers to get a high off the drug. But as the patent was set to expire this week on the original OxyContin formula, addicts everywhere could soon have a new avenue...
-Oxycodone DETERx® resistant to tampering via chewing and crushing CANTON, Mass., April 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced top-line results from its recently completed Phase I clinical trial for Oxycodone DETERx®, its extended-release, abuse-deterrent, multi-particulate product in a capsule form. The product utilizes Collegium's DETERx®...
COLORADO SPRINGS, Colo., April 16, 2013 /PRNewswire/ -- Cannabis Science, Inc. (OTC: CBIS) is pleased to announce Sacred Cow Production presents American Drug War II, a film by Kevin Booth, for national release on June 6, 2013, as Dr. Robert Melamede, President and CEO of Cannabis Science, appears in the film and played a production role. The Company also announces that a private screening event of the film will be held on Thursday, April 18, at 8 p.m. at Casselmans in Denver,...
